WEBMD HEALTH CORP's gross profit margin for the first quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. WEBMD HEALTH CORP is extremely liquid. Currently, the Quick Ratio is 2.10 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.
At the same time, stockholders' equity ("net worth") has significantly decreased by 43.51% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY15||Q1 FY14|
|Net Sales ($mil)||143.34||133.83|
|Net Income ($mil)||10.0||6.27|
|Balance Sheet||Q1 FY15||Q1 FY14|
|Cash & Equiv. ($mil)||735.29||778.4|
|Total Assets ($mil)||1220.28||1283.96|
|Total Debt ($mil)||952.23||952.23|
|Profitability||Q1 FY15||Q1 FY14|
|Gross Profit Margin||59.62||60.72|
|Return on Assets||3.75||1.78|
|Return on Equity||51.35||14.88|
|Debt||Q1 FY15||Q1 FY14|
|Share Data||Q1 FY15||Q1 FY14|
|Shares outstanding (mil)||36.57||38.38|
|Div / share||0.0||0.0|
|Book value / share||2.38||4.01|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||321575.0||348899.0|
HOLD. The current P/E ratio indicates a significant discount compared to an average of 52.45 for the Internet Software & Services industry and a significant premium compared to the S&P 500 average of 21.25. For additional comparison, its price-to-book ratio of 18.25 indicates a significant premium versus the S&P 500 average of 2.83 and a significant premium versus the industry average of 5.40. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. The valuation analysis reveals that, WEBMD HEALTH CORP seems to be trading at a discount to investment alternatives within the industry.
|WBMD 40.57||Peers 52.45||WBMD 12.15||Peers 27.52|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
WBMD is trading at a discount to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
WBMD is trading at a significant discount to its peers.
|WBMD 30.04||Peers 28.12||WBMD 1.27||Peers 0.88|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
WBMD is trading at a premium to its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
WBMD trades at a significant premium to its peers.
|WBMD 18.25||Peers 5.40||WBMD 109.80||Peers 82.85|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
WBMD is trading at a significant premium to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
WBMD is expected to have an earnings growth rate that significantly exceeds its peers.
|WBMD 2.69||Peers 9.47||WBMD 9.99||Peers 30.64|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
WBMD is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
WBMD significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV